Literature DB >> 17606375

Breast conservation for male breast carcinoma.

Mehra Golshan1, Jennifer Rusby, Francisco Dominguez, Barbara L Smith.   

Abstract

Male breast cancer in general is treated by modified radical mastectomy. Data have emerged supporting the replacement of the axillary lymph node dissection by a sentinel lymph node biopsy in the male patient with breast carcinoma. Local therapy in the breast continues to be primarily mastectomy. The reasons suggested for this include the central location of many of the male breast tumors and the paucity of breast tissue. Our experience with breast conservation over the last decade in male breast carcinoma and a review of the literature is outlined here. Between 1996 and 2006, seven men underwent breast conservation for breast carcinoma and to date with a median follow-up of 67 months, there have been no local recurrences. Breast carcinoma in males can be treated with breast conservation with acceptable local recurrence. Breast-conserving surgery in male breast cancer patients should be considered an option in patients without overt nipple/areolar involvement.

Entities:  

Mesh:

Year:  2007        PMID: 17606375     DOI: 10.1016/j.breast.2007.05.012

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  18 in total

1.  Is Breast-Conserving Therapy Appropriate for Male Breast Cancer Patients? A National Cancer Database Analysis.

Authors:  Sarah B Bateni; Anders J Davidson; Mili Arora; Megan E Daly; Susan L Stewart; Richard J Bold; Robert J Canter; Candice A M Sauder
Journal:  Ann Surg Oncol       Date:  2019-02-13       Impact factor: 5.344

2.  Poorer survival outcomes for male breast cancer compared with female breast cancer may be attributable to in-stage migration.

Authors:  Jennifer L Gnerlich; Anjali D Deshpande; Donna B Jeffe; Susmitha Seelam; Eric Kimbuende; Julie A Margenthaler
Journal:  Ann Surg Oncol       Date:  2010-12-14       Impact factor: 5.344

Review 3.  [Male breast cancer: a challenge for urologists].

Authors:  C Hofer; B Schmalfeldt; J E Gschwend; K Herkommer
Journal:  Urologe A       Date:  2010-09       Impact factor: 0.639

Review 4.  Innervation of the Male Breast: Psychological and Physiological Consequences.

Authors:  Laurent Misery; Matthieu Talagas
Journal:  J Mammary Gland Biol Neoplasia       Date:  2017-05-27       Impact factor: 2.673

5.  Clinicopathological Characteristics and Survival Analysis of 87 Male Breast Cancer Cases.

Authors:  Tingting Liu; Zhongsheng Tong; Lihong He; Li Zhang
Journal:  Breast Care (Basel)       Date:  2011-12-20       Impact factor: 2.860

Review 6.  Male breast cancer: an update in diagnosis, treatment and molecular profiling.

Authors:  Susan Onami; Melanie Ozaki; Joanne E Mortimer; Sumanta Kumar Pal
Journal:  Maturitas       Date:  2010-02-06       Impact factor: 4.342

Review 7.  HER2-positive male breast cancer: an update.

Authors:  Laura Ottini; Carlo Capalbo; Piera Rizzolo; Valentina Silvestri; Giuseppe Bronte; Sergio Rizzo; Antonio Russo
Journal:  Breast Cancer (Dove Med Press)       Date:  2010-10-04

8.  A 16-year-old male with gynecomastia and ductal carcinoma in situ.

Authors:  Henry L Chang; Joshua B Kish; Barbara L Smith; Allan M Goldstein
Journal:  Pediatr Surg Int       Date:  2008-09-03       Impact factor: 1.827

9.  Male breast cancer in the United States: Treatment patterns and prognostic factors in the 21st century.

Authors:  Siddhartha Yadav; Dhauna Karam; Irbaz Bin Riaz; Hao Xie; Urshila Durani; Narjust Duma; Karthik V Giridhar; Tina J Hieken; Judy C Boughey; Robert W Mutter; John R Hawse; Rafael E Jimenez; Fergus J Couch; Roberto A Leon-Ferre; Kathryn J Ruddy
Journal:  Cancer       Date:  2019-10-07       Impact factor: 6.860

Review 10.  Image-based screening for men at high risk for breast cancer: Benefits and drawbacks.

Authors:  Ryan W Woods; Lonie R Salkowski; Mai Elezaby; Elizabeth S Burnside; Roberta M Strigel; Amy M Fowler
Journal:  Clin Imaging       Date:  2019-11-28       Impact factor: 1.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.